Related Experiment Video
Updated: Jun 13, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Policy issues and stakeholder concerns regarding the storage and use of residual newborn dried blood samples for
Erin Rothwell1, Rebecca Anderson, Jeffrey Botkin
1University of Utah, Salt Lake City, UT 84112, USA. erin.rothwell@nurs.utah.edu
Insights
Newborn screening policies need more public input. Stakeholder groups consistently emphasized the need for clear guidelines on storing and researching residual newborn screening samples.
Area of Science:
- Public Health
- Genetics
- Bioethics
Background:
- Newborn screening is a vital public health program in the US, screening over 4 million infants annually.
- Existing state policies for the storage and research use of residual newborn samples are often not explicit.
- There is a growing need to address these policy gaps.
Purpose of the Study:
- To explore stakeholder attitudes and opinions regarding policies for residual newborn samples.
- To identify consistent themes from diverse stakeholder groups for policy development.
Main Methods:
- Qualitative study involving three focus groups (n=21) with diverse stakeholders.
- Participants included an African American community group, pediatricians, and mothers of young children.
Main Results:
- Consistent themes emerged across all stakeholder groups regarding storage and research use of residual newborn samples.
- Despite group differences, a shared need for clearer policy direction was evident.
Conclusions:
- The findings suggest a need for further public engagement in developing newborn screening policies.
- Future policy development should incorporate stakeholder input on residual sample management.
Abstract:
Newborn screening is an important public health programs in the United States. Over 4 million infants are screened each year for a number of conditions. There is a growing need for more explicit state policies governing the storage and research use of residual newborn samples. This paper provides an overview of newborn screening and issues related to policies of residual newborn samples as well as attitudes and opinions from stakeholders. Three groups (n = 21) were conducted with stakeholders: an African American group, a Pediatrician group and a Mothers of young children group. Despite the differences between these groups, consistent themes emerged from all groups that may be relevant for policy development governing the storage and use of residual newborn samples. The data from this exploratory study suggest that future policy developments with the newborn screening program warrant further public input on these topics.
Related Concept Videos
Ethical Issues
Ethical Concerns in Healthcare:
Ethics in Research
Stem Cell Culture
CRISPR

